Drug Shortage Report for FASTURTEC
| Report ID | 179050 |
| Drug Identification Number | 02248416 |
| Brand name | FASTURTEC |
| Common or Proper name | FASTURTEC 1.5 mg/vial |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RASBURICASE |
| Strength(s) | 1.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 3 |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2023-01-18 |
| Actual start date | |
| Estimated end date | 2023-02-20 |
| Actual end date | 2023-01-30 |
| Shortage status | Resolved |
| Updated date | 2023-01-31 |
| Company comments | Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-01-31 | English | Compare |
| v7 | 2023-01-30 | French | Compare |
| v6 | 2023-01-30 | English | Compare |
| v5 | 2023-01-19 | English | Compare |
| v4 | 2023-01-12 | French | Compare |
| v3 | 2023-01-12 | English | Compare |
| v2 | 2022-12-21 | French | Compare |
| v1 | 2022-12-21 | English | Compare |
Showing 1 to 8 of 8